SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000882104-14-000007
Filing Date
2014-03-03
Accepted
2014-03-03 16:04:08
Documents
16
Period of Report
2014-03-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pdli-20140303x8xkdoc.htm 8-K 32763
2 PRESS RELEASE pdli-20140303x8xkex991.htm EX-99.1 190274
3 PRESENTATION pdli-20140303x8xkex992.htm EX-99.2 6121
4 INFORMATION SHEET pdli-20140303x8xkex993.htm EX-99.3 737608
5 pdllogo75a01.jpg GRAPHIC 5218
6 slide1a04.jpg GRAPHIC 75014
7 slide2a04.jpg GRAPHIC 137172
8 slide3a04.jpg GRAPHIC 62547
9 slide4a04.jpg GRAPHIC 53461
10 slide5a04.jpg GRAPHIC 105341
11 slide6a04.jpg GRAPHIC 69418
12 slide7a04.jpg GRAPHIC 64592
13 slide8a04.jpg GRAPHIC 61051
14 slide9a04.jpg GRAPHIC 68573
15 slide10a04.jpg GRAPHIC 96798
16 slide11a04.jpg GRAPHIC 65504
  Complete submission text file 0000882104-14-000007.txt   2160838
Mailing Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451
Business Address 932 SOUTHWOOD BLVD INCLINE VILLAGE NV 89451 775-832-8500
PDL BIOPHARMA, INC. (Filer) CIK: 0000882104 (see all company filings)

IRS No.: 943023969 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19756 | Film No.: 14660315
SIC: 2836 Biological Products, (No Diagnostic Substances)